Lenalidomide hemihydrate

IUPAC name




Molecular Weight

536.5 g·mol−1

Molecular Formula


Granule:    Available

Ready to press o

Ready to fill þ

Mechanism Of Action:

·       Exhibits immunomodulatory properties.

Activates and increases number of T cells and NK cells

Increases number of NKT cells

Inhibits pro-inflammatory cytokines (e.g., TNF-a, and IL-6) by monocytes

·       Inhibits cell proliferation and induces apoptosis of tumor cells in vitro and inhibition of tumor growth in vivo, leading to a decrease in tumor burden.

·       Inhibits angiogenesis by reducing levels of VEGF, TNF-a, and IL-6.


  • Newly diagnosed multiple myeloma(MM) in patients who have undergone/ or not eligible for autologous stem cell transplantation, and Multiple myeloma in patients who have received at least one prior therapy
  • Myelodysplastic syndromes(MDS)
  • Mantle cell lymphoma(MCL)
  • Follicular lymphoma